News about Market

Roche Secures FDA CLIA Waiver and CE Mark for Bordetella POC Test

Roche has received CE Mark approval for its first point-of-care test capable of diagnosing and differentiating Bordetella infections, including whooping cough, within 15 minutes. The rapid, PCR-accurate test enables faster clinical decisions and supports early intervention, particularly for vulnerable groups such as infants and the elderly.

Market | 03/12/2025 | By Dineshwori |  260

Lilly Lowers Zepbound's Single-dose Vials' Cost

Lilly has reduced the price of its Zepbound (tirzepatide) single-dose vials, reinforcing its commitment to improving affordability and expanding access for people living with obesity.

Market | 02/12/2025 | By Dineshwori |  311

Biocon Biologics Reaches Settlement with Amgen, Secures Market Entry Date for Denosumab Biosimilars

Biocon Biologics will introduce both its Denosumab biosimilars — Vevzuo and Evfraxy — in Europe beginning December 2, 2025. Other terms of the settlement with Amgen remain confidential.

Market | 02/12/2025 | By Dineshwori |  129

Sun Pharma Introduces ILUMYA in India for Plaque Psoriasis Treatment

Sun Pharma has launched its global innovative drug, ILUMYA (Tildrakizumab), in India for the treatment of moderate-to-severe plaque psoriasis.

Market | 01/12/2025 | By Dineshwori |  200

Lung Cancer Canada and Boehringer Ingelheim Canada Partner to Advance NSCLC Diagnostics

Lung Cancer Canada and Boehringer Ingelheim have launched a two-stage initiative to accelerate innovation in NSCLC diagnostics. The effort begins with a national Diagnostic Innovation Lab to identify key barriers in diagnosis, followed by an innovation challenge seeking solutions to close those gaps.

Market | 29/11/2025 | By Dineshwori |  195

SK Biopharmaceuticals Expands Radiopharma Portfolio with New WARF In-Licensing

SK Biopharmaceuticals has in-licensed a second radiopharmaceutical therapy candidate from the Wisconsin Alumni Research Foundation (WARF), further strengthening its pipeline and advancing its strategy to build an integrated, globally competitive radiotherapeutics portfolio.

Market | 29/11/2025 | By Dineshwori |  290

Cipla Launches India's First Dedicated Lung Health Diagnostics Centre in Delhi

Cipla has opened the country’s first dedicated lung diagnostics centre in Delhi, equipped to conduct over 60 tests across respiratory function, microbial studies, immune profiling, blood chemistry and imaging.

Market | 29/11/2025 | By Dineshwori |  209

GV20 Therapeutics Hits Milestone in ADC Collaboration with Mitsubishi Tanabe Pharma

GV20 Therapeutics has secured a milestone payment from Mitsubishi Tanabe Pharma under their 2025 collaboration to develop the first-in-class Antibody Drug Conjugates (ADCs) using GV20’s STEAD AI–discovered tumour-targeting antibodies.

Market | 28/11/2025 | By Dineshwori |  298

Exyte Completes Pharmaplan's Integration

The completed integration of Pharmaplan marks a major milestone in Exyte’s strategy to build a leading European player in life sciences engineering and strengthen collaboration with the region’s biotechnology and pharmaceutical industries.

Market | 28/11/2025 | By Dineshwori |  295

Crane NXT to Acquire Antares Vision, Plans Take-Private Deal

Crane NXT, a leading industrial technology company, announced that it has signed definitive agreements to acquire a significant stake in Antares Vision S.p.A., with plans to take the company private.

Market | 28/11/2025 | By Darshana |  156